With borderline ischemia on nuclear stress testing showing ST‑segment depression, no angina, normal perfusion, a coronary calcium score of 94.3 in the left anterior descending artery, and mild grade I diastolic dysfunction with left‑ventricular concentric hypertrophy, what does the comment that my heart may not be getting enough oxygen mean and should I pursue further evaluation for a flow‑limiting LAD lesion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Understanding "Borderline Ischemia" and the Comment About Oxygen Supply

Your heart failure specialist's comment that "your heart may not be getting enough oxygen" likely refers to the combination of your mild diastolic dysfunction, left ventricular hypertrophy, and coronary calcium in the LAD—not necessarily flow-limiting epicardial coronary disease, since your nuclear perfusion was normal. This represents a mismatch between oxygen supply and demand at the myocardial level, potentially from coronary microvascular dysfunction rather than obstructive coronary artery disease 1.

What "Borderline Ischemia" Means on Nuclear Stress Testing

Borderline ischemia typically indicates subtle perfusion abnormalities with a summed stress score (SSS) of 1-3 and/or summed difference score (SDS) of 1, which falls below the threshold for definitive ischemia but suggests some degree of coronary circulatory impairment 2.

  • ST-segment depression during stress testing refers to downward displacement of the ST segment below the isoelectric line by ≥1 mm, measured 80 milliseconds from the J-point 3, 4.
  • However, your nuclear perfusion was reported as normal, which creates an apparent discordance between the ECG changes (ST depression suggesting ischemia) and the perfusion imaging (showing no significant defects) 5.
  • This discordance is clinically important: studies show that 2-9% of patients with normal or near-normal myocardial perfusion imaging can still have severe coronary artery disease, particularly when other markers of ischemia are present 5.

The Significance of Your Calcium Score

A coronary calcium score of 94.3 exclusively in the LAD places you in an intermediate-risk category (CAC 100-399 Agatston units) for future cardiac events 6.

  • This score indicates established atherosclerotic plaque burden in the LAD territory 6.
  • However, calcium scoring cannot distinguish between stable and vulnerable plaque, nor does it reliably predict the functional significance of stenoses 6.
  • Among patients with borderline ischemia who undergo angiography, obstructive CAD (≥70% stenosis or left main ≥50%) is found in approximately 40.5% of cases 2.

Understanding the Oxygen Supply Comment

The specialist's statement reflects three potential mechanisms operating simultaneously in your case:

1. Diastolic Dysfunction and Increased Oxygen Demand

  • Grade I diastolic dysfunction with mild left ventricular concentric hypertrophy increases myocardial oxygen demand because the thickened heart muscle requires more oxygen to function 6.
  • The hypertrophied myocardium also has impaired relaxation, which compromises coronary perfusion during diastole when most coronary blood flow occurs 7.

2. Coronary Microvascular Dysfunction

  • Normal epicardial perfusion on nuclear imaging does not exclude coronary microvascular dysfunction (CMD), which can cause myocardial ischemia without obstructive coronary disease 1, 8.
  • Recent evidence demonstrates that exercise-induced ST-segment depression in patients with angina and non-obstructive coronary arteries (ANOCA) is 100% specific for CMD when validated against invasive coronary physiological testing 1.
  • This means your ST-segment changes during stress may reflect microvascular ischemia rather than epicardial coronary obstruction 1.

3. Balanced Ischemia Masking True Disease Burden

  • When severe multivessel disease is present, nuclear perfusion imaging may appear falsely normal because all territories are equally underperfused—a phenomenon called "balanced ischemia" 9, 5.
  • Key markers that suggest severe CAD despite normal perfusion include: ST-segment depression ≥2 mm, transient ischemic cavity dilation, increased lung uptake of tracer, and stress-induced hypotension 6, 5.

Should You Pursue Further Evaluation for LAD Disease?

Yes, further evaluation is warranted given the constellation of findings, but the approach should be tailored to whether you have ongoing symptoms and the presence of high-risk features.

Indications for Invasive Coronary Angiography

You should proceed to invasive coronary angiography with fractional flow reserve (FFR) capability if any of the following apply 6, 10, 7:

  • Frequent or progressive anginal symptoms despite medical therapy (even if mild, given your concern about decreased cardiac force)
  • High-risk features on stress testing: ≥2 mm ST-segment depression, ST depression at low workload, ST depression persisting into recovery, or exercise-induced hypotension 6
  • Proximal LAD disease with intermediate stenosis (50-70%) on coronary CT angiography, if performed, would be appropriate for revascularization given your symptoms 10

Alternative Approach: Coronary CT Angiography First

If you do not have high-risk stress features, coronary CT angiography (CCTA) with FFR-CT is reasonable as the next step 7, 4:

  • CCTA can definitively rule out obstructive LAD disease and assess plaque characteristics 7.
  • If CCTA shows ≥70% stenosis in the proximal LAD, this constitutes high-risk anatomy warranting invasive angiography and likely revascularization 6, 7.
  • FFR-CT can assess the functional significance of intermediate stenoses (50-69%) without additional testing 4.

Assessment for Coronary Microvascular Dysfunction

If invasive angiography shows no obstructive disease, you should undergo comprehensive coronary physiological assessment including 1, 8:

  • Invasive coronary flow reserve (CFR) measurement with adenosine to assess endothelium-independent microvascular function
  • Acetylcholine testing to assess endothelium-dependent microvascular function and vasospasm
  • This approach is particularly important given your ST-segment changes with normal perfusion, which is highly specific for CMD 1.

Clinical Pitfalls to Avoid

Do not dismiss your symptoms or delay evaluation based solely on "normal perfusion" 5:

  • The combination of ST-segment depression, calcium in the LAD, and your subjective sense of decreased cardiac force warrants anatomic evaluation 5.
  • Borderline ischemia is associated with higher rates of obstructive CAD (40.5%) and increased coronary revascularization procedures, even if it doesn't predict hard cardiac events 2.

Do not assume that absence of angina during testing excludes significant disease 9:

  • Silent ischemia is common, particularly in patients with diabetes or diastolic dysfunction 7.
  • Your subjective perception of decreased cardiac force may represent a symptom equivalent of angina 4.

Recommended Next Steps

Based on current guidelines and your specific presentation, the following algorithm is appropriate 7, 4:

  1. Optimize medical therapy for diastolic dysfunction and coronary risk factors while pursuing diagnostic evaluation
  2. Obtain coronary CT angiography with FFR-CT capability as the next diagnostic test to define LAD anatomy 7, 4
  3. If CCTA shows ≥70% proximal LAD stenosis or FFR-CT ≤0.80: proceed to invasive angiography with FFR and consider revascularization 7, 4
  4. If CCTA shows non-obstructive disease but symptoms persist: proceed to invasive angiography with comprehensive coronary physiological testing (CFR and acetylcholine) to diagnose CMD 1, 8
  5. If CMD is confirmed: targeted medical therapy with ranolazine, calcium channel blockers, or other microvascular-directed therapies 8

The key message is that your symptoms and test findings warrant anatomic clarification of the LAD, and if no obstructive disease is found, functional assessment for microvascular dysfunction should follow 1, 8.

References

Research

The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2022

Related Questions

In a patient with a normal myocardial perfusion imaging (MPI) stress test showing a 64% left ventricular ejection fraction and no reversible ischemia, can coronary artery disease still be present?
How do I convert a summed difference score (SDS) to the percentage of myocardial ischemia?
Can shoulder pain lasting seven days be the only presenting symptom of a cardiac condition such as myocardial ischemia or infarction?
Is this presentation demand (supply‑demand) ischemia or type 2 myocardial infarction?
What is the new classification of myocardial infarction according to the 2026 guidelines?
What benzodiazepine dosing regimen is recommended for preventing alcohol withdrawal, including agent selection, dosing schedule, and adjustments for hepatic impairment or elderly patients?
What is the recommended loading dose of clopidogrel?
What are the examination findings in rheumatic heart disease?
What does it mean that MRI shows mild diffuse posterior disc bulges at C4‑C5 and C5‑C6 mildly effacing the anterior subarachnoid space without cord or nerve root compromise, and a diminished bright T2 signal at L4‑L5 with a diffuse posterior disc bulge effacing epidural fat, flattening the thecal sac, and mildly encroaching the neural foramina?
How should cardiac auscultation be performed and what findings should be assessed?
How should I manage a 40-year-old man with persistent erectile dysfunction after discontinuing finasteride three months ago, high‑normal total testosterone, normal free testosterone, elevated sex‑hormone‑binding globulin, on sertraline, who now has new sugar cravings, increased appetite, low white‑blood‑cell count and microcytic anemia (low mean corpuscular volume)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.